Fig 3.
Longitudinal neutrophils(3A) and lymphocytes(3B) kinetics of ARD patients and healthy controls (HC) after fractional-dose YFV.Values (cell/mm3) represent the mean ± SD of measures for each tiime-point: day 0 or baseline (D0), day 5 (D5), day 10 (D10), and day 30 (D30). The n for ARD patients per day is D0 (n = 159), D5 (n = 148), D10 (n = 147), and D30 (n = 149) and for controls is D0 (n = 159), D5 (n = 158), D10 (n = 156), and D30 (n = 149). *p < 0.05 and ***p < 0.001 compared to day 0 (D0).
